Journal of
eISSN: 2376-0060
Submit manuscript...
Mini Review Volume 13 Issue 2
Dual phosphodiesterase 3 and 4 inhibition in chronic obstructive pulmonary disease: mechanistic rationale and clinical translation of Ensifentrine
Prakhar Anand, Mark Georgy, Yashi Ballal, Mahtab Nezafat, Raghav Gupta
Received: June 17, 2026 | Published: June 24, 2026
Citation: Anand P, Georgy M, Ballal Y, et al. Dual phosphodiesterase 3 and 4 inhibition in chronic obstructive pulmonary disease: mechanistic rationale and clinical translation of Ensifentrine. J Lung Pulm Respir Res. 2026;13(2):34-38. DOI: 10.15406/jlprr.2026.13.00342
©2026 Anand, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.